People · Operator
Named in public records as an officer, director or promoter · active 2014–2021 · Other Health Care, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| IVXpress, Inc. | — | Other Health Care | Series D+ | $164.0M | $1.8B | 2019 |
| Ginger.io, Inc. | — | Software / Tech | Series C | $99.1M | $1.5B | 2014 |
Dave Schulte at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dave Schulte on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jon Callaghan | 1 | 20 |
| Bruce Armstrong | 1 | 10 |
| David ibnAle | 1 | 7 |
| Steve Kraus | 1 | 6 |
| Russell Glass | 1 | 5 |
| Ainslie Mayberry | 1 | 4 |
| Andrew Kim | 1 | 4 |
| Sam Brasch | 1 | 4 |
| Molly Coye | 1 | 3 |
| Ryan Phillips | 1 | 3 |
| Michael Fiore | 1 | 2 |
| Alex Pentland | 1 | 2 |
| Mark Taber | 1 | 2 |
| Anmol Madan | 1 | 2 |
| William Seibels | 1 | 2 |
| Douglas Ghertner | 1 | 1 |
| Marty Felsenthal | 1 | 1 |
| Andrew E. Kim | 1 | 1 |
| Michael E. Fiore | 1 | 1 |
| James E. Lippert | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.